{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-007607","form_type":"8-K","ticker":"HRGN","cik":"0001563665","company_name":"Harvard Apparatus Regenerative Technology, Inc.","filed_at":"2023-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.594374+00:00","generated_at":"2026-06-18T03:16:35.870960+00:00","sec_items":["3.02","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biostage appoints Jerry He as CEO, replacing David Green; sets compensation terms","bullets":["Jerry He appointed Chairman and CEO effective March 1, 2023; David Green remains on board.","Base salary $300,000, rising to $500,000 if private placement raises ≥$4M.","Time-based option grant: 732,384 shares; milestone grant up to 488,256 shares.","If offering raises <$4M, annual option grant valued at $200,000 in lieu of additional cash.","Annual bonus up to 100% of base salary."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-007607","json":"https://secwatch.observer/filing/0001493152-23-007607.json","markdown":"https://secwatch.observer/filing/0001493152-23-007607.md","text":"https://secwatch.observer/filing/0001493152-23-007607.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/0001493152-23-007607-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T03:16:35.870960+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"31a91c2607","claim":"David Green changed role as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..","evidence_excerpt":"the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/0001493152-23-007607-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"replaced"},{"label":"Role","value":"Chairman and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"521e4e42a9","claim":"Junli (Jerry) He was appointed as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..","evidence_excerpt":"the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1563665/000149315223007607/0001493152-23-007607-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}